Le Lézard
Classified in: Health
Subjects: PDT, TRI

SkinCeuticals Announces the Launch of Clear Daily Soothing UV Defense SPF 50


SkinCeuticals Brings Sensitive Skin Protection to New Heights with Patented Netlock UV Technology

NEW YORK, May 1, 2024 /PRNewswire/ -- SkinCeuticals, the #1 Medical Skincare Brand, announces the launch of Clear Daily Soothing UV Defense SPF 50, a transparent, non-comedogenic daily-use sunscreen. This new hybrid-blend SPF offers a potent blend of protection, hydration, and soothing benefits with a cast-free, blendable finish, tested across all skin tones.

SkinCeuticals Clear Daily Soothing UV Defense SPF 50 targets sensitive skin, the leading category of the photoprotection market.1 UV exposure worsens sensitive skin symptoms through inflammation by initiating the inflammation cascade, triggering the over production of pro-inflammatory mediators and increasing symptoms of sensitivity, thus worsening skin redness and breakouts. Clear Daily Soothing UV Defense SPF 50 addresses this issue by offering a comprehensive defense against UV exposure, helping to minimize symptoms such as redness, dryness, and discomfort.

Clear Daily Soothing UV Defense SPF 50 is crafted with a blend of 2.5% Tripeptide and 0.5% Bisabolol to help reduce inflammation and visible skin redness across all skin tones, 7% Glycerin to provide hydration and protection, and a patented Netlock UV technology with a blend of Zinc Oxide, Homosalate, and Octisalate, which work together to provide more effective sun protection. Clear Daily Soothing UV Defense SPF 50 boasts a thorough dossier of clinical testing to demonstrate its efficacy.

"This product meets the needs of transparent photoprotection without compromising efficacy or elegance of the formula, particularly for individuals with sensitive skin," states Angela Hildebrand, General Manager of SkinCeuticals U.S. "Our goal was to expand our award-winning SPF portfolio, launching Clear Daily Soothing UV Defense SPF 50 with our patented Netlock UV technology, that exemplifies our positioning as a pioneer in advanced skincare backed by science."

"Sensitive skin requires extra care when it comes to sun protection, as traditional sunscreens can often cause irritation or discomfort," remarks SkinCeuticals Partner Physician Dr. Vicki Rapaport. "This innovative formula not only provides excellent protection against harmful UV rays, but also soothes and hydrates the skin, making it an invaluable addition to any skincare routine."

To use, apply liberally to the face, neck, and chest 15 minutes before sun exposure and before applying makeup. Reapply sunscreen after 40 minutes of swimming, sweating, immediately after towel drying, and at least every two hours. For children under six months of age, consult a physician before use.
Shake well before use.

SkinCeuticals Clear Daily Soothing UV Defense SPF 50 is available for $54 at partner skincare professionals nationwide near you (find yours at skinceuticals.com/locate) as well as SkinCeuticals.com.

ABOUT SKINCEUTICALS
SkinCeuticals®, the #1 medical skincare brand in the U.S. and leader in antioxidant technology, founded in Dallas, TX in 1997, discovers, develops, and delivers an advanced line of scientifically backed cosmeceutical treatments. SkinCeuticals® products have been shown to dramatically improve skin health by protecting skin from environmental damage and visibly improving skin clarity, tone, and texture to minimize the appearance of fine lines and wrinkles. SkinCeuticals® is available in over 6,000 physician offices nationwide, with over 100 of those dermatologists and plastic surgeons exclusively selling SkinCeuticals® through their flagship program and SkinCeuticals SkinLabtm destinations which specifically emphasize the SkinCeuticals integrated skincare approach ? combining clinical skincare with in-office treatments. For more information, visit the brand on Facebook, Twitter or Instagram, or at www.SkinCeuticals.com.

CONTACT
Laura Cummins at SkinCeuticals: (212) 984-4907 / [email protected]

1Sources: BMS 2022 ? IRI-Nielsen-SRI-Kantar-IQVIA-ATV-NPD-Beauté Research / evol% vs YAG
https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.2066

SOURCE SkinCeuticals


These press releases may also interest you

at 10:20
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005...

at 10:13
FDNA Inc, the leader in the early detection of rare genetic diseases, and Genome Medical, the nation's leading telehealth provider of genetic services, have partnered to empower parents to detect potential developmental, neurological and...

at 10:11
Most parents are used to hearing pediatricians discourage screen time for kids, but during National Safe Sun Week doctors are actually asking for more ? sunscreen time that is! Keeping skin protected by increasing summer "screen time" is a major...

at 10:02
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDMtm Platform. Located in Belo Horizonte, Brazil, the Instituto Mário Penna...

at 10:01
Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces the results of a groundbreaking independent study led by Mayo Clinic and presented at Digestive Disease Week...

at 10:00
Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA). A new trial led by the Center for Regenerative Medicine...



News published on and distributed by: